Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-034654
Filing Date
2022-02-10
Accepted
2022-02-10 17:15:52
Documents
1
Group Members
CHRISTIAN ANGERMAYERPRESIGHT SENSEI CO-INVEST FUND, L.P.PRESIGHT SENSEI CO-INVEST MANAGEMENT, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d273019dsc13ga.htm SC 13G/A 89445
  Complete submission text file 0001193125-22-034654.txt   91120
Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000
Sensei Biotherapeutics, Inc. (Subject) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92222 | Film No.: 22615312
SIC: 2834 Pharmaceutical Preparations

Mailing Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605
Business Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605 44 7557 251 563
Apeiron Investment Group Ltd. (Filed by) CIK: 0001845711 (see all company filings)

EIN.: 000000000 | State of Incorp.: O1 | Fiscal Year End: 1231
Type: SC 13G/A